Physician profile
Elbert Chang
NPI 1215460712
$7,190.39
in general payments reported to CMS, 2019-2025
15 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $24.07 · 2021: $97.89 · 2022: $57.37 · 2023: $857 · 2024: $5,484 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,615 · Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,614.71 |
| Food and Beverage | $1,017.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,992.08 | 2023-2024 | Da Vinci Surgical System |
| Abbvie INC. | $531.85 | 2019-2023 | Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $152.47 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $93.75 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $74.25 | 2025 | Ally II Ups |
| Medtronic, INC. | $48.76 | 2024-2025 | Ligasure, Truclear |
| Mayne Pharma Commercial LLC | $47.75 | 2024-2025 | |
| Shield Therapeutics INC | $47.44 | 2024 | |
| Hologic Sales and Service, LLC | $45.63 | 2023-2025 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Urovant Sciences INC | $38.73 | 2022 | |
| Exeltis, USA INC. | $34.98 | 2023 | Slynd |
| Biogen, INC. | $28.72 | 2025 | Zurzuvae |
| Minerva Surgical, INC | $21.05 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.59 | 2021 | |
| Organon LLC | $16.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elbert Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.